197 results on '"Ambrosino, Donna"'
Search Results
2. Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial
3. Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
4. CD209L (L-SIGN) Is a Receptor for Severe Acute Respiratory Syndrome Coronavirus
5. Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults
6. SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.
7. Heterologous boosting of neutralizing activity against Delta and Omicron SARS-CoV-2 variants in CoronaVac-primed adults; a randomized study with SCB-2019 vaccine
8. Protection from Omicron and other VOCs by Bivalent S-Trimer COVID-19 Vaccine
9. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates
10. Towards a population-based threshold of protection for COVID-19 vaccines
11. Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines
12. Therapy with a Severe Acute Respiratory Syndrome-Associated Coronavirus-Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters
13. Development and Characterization of a Severe Acute Respiratory Syndrome-Associated CoronavirusNeutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice [with Discussion]
14. Immunogenicity of SCB-2019 COVID-19 Vaccine Compared to Four Approved Vaccines
15. A Population-Based Threshold of Protection for COVID-19 Vaccines
16. Normal IgG and Impaired IgM Responses to Polysaccharide Vaccines in Asplenic Patients
17. Reduction of Respiratory Syncytial Virus (RSV) in Tracheal Aspirates in Intubated Infants by Use of Humanized Monoclonal Antibody to RSV F Protein
18. Evidence for antibody as a protective correlate for COVID-19 vaccines
19. Broad neutralization against SARS-CoV-2 variants induced by a modified B.1.351 protein-based COVID-19 vaccine candidate
20. Pneumococcal Conjugate Vaccine Primes for Antibody Responses to Polysaccharide Pneumococcal Vaccine after Treatment of Hodgkin's Disease
21. Treatment with monoclonal antibodies against clostridium difficile toxins
22. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates
23. Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
24. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins
25. Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines.
26. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice
27. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation
28. Effect of monophosphoryl lipid A (MPL ®) on T-helper cells when administered as an adjuvant with pneumocococcal–CRM 197 conjugate vaccine in healthy toddlers
29. Antibody Responses to Polysaccharide and Polysaccharide-Conjugate Vaccines after Treatment of Hodgkin Disease
30. Antibody Response of Infants to Haemophilus influenzae Type b Capsular Polysaccharide Combined with Bordetella pertussis
31. Passive Immunization against Disease Due to Haemophilus influenzae Type b: Concentrations of Antibody to Capsular Polysaccharide in High-Risk Children
32. Simultaneous Administration of Vaccines for Haemophilus influenzae Type b, Pneumococci, and Meningococci
33. κ and λ Light Chain Composition of Antibody to the Capsular Polysaccharide of Haemophilus influenzae Type b
34. History of passive antibody administration for prevention and treatment of infectious diseases
35. High-Throughput Sequencing Analysis of Post-Liver Transplantation HCV E2 Glycoprotein Evolution in the Presence and Absence of Neutralizing Monoclonal Antibody
36. Prevention of Haemophilus influenzae type B infections in high-risk infants treated with bacterial polysaccharide immune globulin
37. An immunodeficiency characterized by impaired antibody responses to polysaccharides
38. Identification of Human Monoclonal Antibodies Specific for Human SOD1 Recognizing Distinct Epitopes and Forms of SOD1
39. Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
40. Blood-Group-A-Like Substance in a Preparation of Pneumococcal Vaccine
41. Treatment with Monoclonal Antibodies againstClostridium difficileToxins
42. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
43. Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
44. 751b Phase II Efficacy of Human Monoclonal Antibody Treatment to Prevent C. difficile Recurrence
45. Recombinant Protein-Based Assays for Detection of Antibodies to Severe Acute Respiratory Syndrome Coronavirus Spike and Nucleocapsid Proteins
46. Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile -Induced Mortality in Hamsters
47. Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with Receptor
48. Effect of monophosphoryl lipid A (MPL®) on T-helper cells when administered as an adjuvant with pneumocococcal–CRM197 conjugate vaccine in healthy toddlers
49. Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions
50. RESPIRATORY SYNCYTIAL VIRUS VACCINES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.